FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41210911000001108: Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Dec 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2506041000001117 Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2506051000001119 Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Is a Tezepelumab 210mg/1.91ml solution for injection pre-filled syringes true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Is a Tezspire true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has specific active ingredient Tezepelumab true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) 1 pre-filled disposable injection Has AMP True Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start